<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03115086</url>
  </required_header>
  <id_info>
    <org_study_id>031CHO15001</org_study_id>
    <nct_id>NCT03115086</nct_id>
  </id_info>
  <brief_title>The REPLACE Registry</brief_title>
  <official_title>A Prospective, Observational, Non-Interventional, Post-Marketing, Patient Registry to Collect Data on Routine Clinical Care in Patients Treated With Cholbam®/Kolbam® (Cholic Acid)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Retrophin, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Retrophin, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a prospective, observational, non-interventional patient registry designed to
      document long term safety and clinical outcomes for 10 years in patients treated with
      Cholbam/Kolbam, including those who have been using Cholbam/Kolbam and those who start
      Cholbam/Kolbam treatment at enrollment.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      No experimental intervention is involved; patients in the Registry undergo clinical
      assessments and receive care as determined by the patient's treating physician.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 10, 2017</start_date>
  <completion_date type="Anticipated">August 2030</completion_date>
  <primary_completion_date type="Anticipated">July 2030</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>10 Years</target_duration>
  <primary_outcome>
    <measure>Number of Participants with New-Onset or Worsening Cholestasis</measure>
    <time_frame>10 Years</time_frame>
    <description>Safety and effectiveness will be measured by new-onset or worsening cholestasis. Worsening cholestasis will be identified by measuring direct total bilirubin concentration, and will be defined as a 25% increase from previous measurement if the total bilirubin is &gt;1mg/dL. New-onset cholestasis will be identified by detecting abnormal direct bilirubin concentration &gt;1mg/dL or direct bilirubin greater than 20% of the total bilirubin if total bilirubin is &gt;5mg/dL.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Participants with Steatorrhea Leading to Poor Growth</measure>
    <time_frame>10 Years</time_frame>
    <description>Safety and effectiveness will be measured by steatorrhea leading to poor growth in children, which will be defined as a decrease in percentiles from the original percentile at enrollment to the registry study.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Participants changes in Serum Levels of Fat Soluble Vitamins</measure>
    <time_frame>10 Years</time_frame>
    <description>Safety and effectiveness will be measured changes in serum levels of fat soluble vitamins measured by deficiencies identified by comparing results from serum assays (Vitamin A: Retinol, Vitamin D: 250HD2 + 250HD3, Vitamin K: Serum Vitamin K, Vitamin E: Serum Vitamin E) for each vitamin with standard ranges.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Participants with Growth Failure</measure>
    <time_frame>10 Years</time_frame>
    <description>Safety and effectiveness will be measured by growth failure will be defined as a decrease in percentiles from the original percentile at entry point into the registry study.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Participants with Treated Related Adverse Events</measure>
    <time_frame>10 years</time_frame>
    <description>Number of participants with treatment-related adverse events as assessed by CTCAE v4.0</description>
  </primary_outcome>
  <enrollment type="Anticipated">110</enrollment>
  <condition>Bile Acid Synthesis Disorders</condition>
  <eligibility>
    <study_pop>
      <textblock>
        All patients with a diagnosis for which Cholbam/Kolbam is indicated are eligible for
        inclusion in the Registry.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Male and female patients, of any age.

          2. The patient has a diagnosis for which Cholbam/Kolbam is indicated.

          3. The patient is treated with Cholbam/Kolbam at enrollment.

        Exclusion Criteria:

        1. Patients who will not be able to comply with the requirements of the protocol will be
        excluded.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Retrophin Medical Information</last_name>
    <phone>1-877-659-5518</phone>
    <email>medinfo@retrophin.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Alabama Birmingham</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35233</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Janaina Nogueira-Souza</last_name>
      <phone>205-638-9918</phone>
      <email>JNogueira@peds.uab.edu</email>
    </contact>
    <contact_backup>
      <last_name>Meg Mosteller-Barnum</last_name>
      <phone>1.205.638.5843</phone>
      <email>lbarnum@peds.uab.edu</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Stanford School of Medicine</name>
      <address>
        <city>Palo Alto</city>
        <state>California</state>
        <zip>94305</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gregory Enns</last_name>
      <phone>650-498-5798</phone>
      <email>genns@stanford.edu</email>
    </contact>
    <contact_backup>
      <last_name>Thu Quan</last_name>
      <phone>650-736-8166</phone>
      <email>tquan@stanford.edu</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>UC San Francisco</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94158</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Phillip Rosenthal</last_name>
      <phone>415-476-7114</phone>
      <email>prosenth@ucsf.edu</email>
    </contact>
    <contact_backup>
      <last_name>Natasha Feier</last_name>
      <phone>415-476-1539</phone>
      <email>natasha.feier@ucsf.edu</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Miami Children's Hospital</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33155</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Erick Hernandez, MD</last_name>
      <phone>305-243-4029</phone>
      <email>Erick.Hernandez@mch.com</email>
    </contact>
    <contact_backup>
      <last_name>Rebeca Deleon</last_name>
      <phone>786-624-3829</phone>
      <email>Rebeca.deleon@mch.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Children's Center For Digestive Health</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30342</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jeffery Lewis</last_name>
      <phone>404-257-0799</phone>
      <email>jlewis@ccdhc.org</email>
    </contact>
    <contact_backup>
      <last_name>Angela Stallworth</last_name>
      <phone>404-503-2291</phone>
      <email>astallworth@gicareforkids.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Washington University at St Louis</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Yumirle Turmelle</last_name>
      <phone>314-454-4030</phone>
      <email>Turmelle_Y@kids.wustl.edu</email>
    </contact>
    <contact_backup>
      <last_name>Stacy Postma</last_name>
      <phone>314-747-5931</phone>
      <email>postmas@wustl.edu</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Icahn School Of Medicine at Mount Sinai</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10029</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ronen Arnon</last_name>
      <phone>212-659-8060</phone>
      <email>ronen.arnon@mountsinai.org</email>
    </contact>
    <contact_backup>
      <last_name>Beatrice Secheli</last_name>
      <phone>212-659-8046</phone>
      <email>Beatrice.Secheli@MountSinai.org</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Montefiore Medical Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10032</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Nadia Ovchinsky</last_name>
      <phone>718-741-2332</phone>
      <email>novchins@montefiore.org</email>
    </contact>
    <contact_backup>
      <last_name>Trang Nguyen</last_name>
      <email>trannguy@montefiore.org</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>UNC Chapel Hill</name>
      <address>
        <city>Chapel Hill</city>
        <state>North Carolina</state>
        <zip>27599</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Steve Lichtman</last_name>
      <phone>919-966-2419</phone>
      <email>Lichtman@med.unc.edu</email>
    </contact>
    <contact_backup>
      <last_name>Nancy Garbarino</last_name>
      <phone>919-843-8734</phone>
      <email>Nancy84@med.unc.edu</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Cincinnati Children's Hospital Medical Center</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45229</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>James E Heubi, MD</last_name>
      <phone>513-636-8046</phone>
      <email>james.heubi@cchmc.org</email>
    </contact>
    <contact_backup>
      <last_name>Andre Hawkins</last_name>
      <email>andre.hawkins@cchmc.org</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Monroe-Carell Jr. Children's Hospital at Vanderbilt</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37232</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lynette Gillis, MD</last_name>
      <phone>615-322-7449</phone>
      <email>Lynette.Gillis@vanderbilt.edu</email>
    </contact>
    <contact_backup>
      <last_name>Jessica Lugo</last_name>
      <phone>(615) 343-4929</phone>
      <email>jessica.m.lugo@vanderbilt.edu</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 10, 2017</study_first_submitted>
  <study_first_submitted_qc>April 10, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 14, 2017</study_first_posted>
  <last_update_submitted>March 28, 2018</last_update_submitted>
  <last_update_submitted_qc>March 28, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 29, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Bile Acid Synthesis Disorder</keyword>
  <keyword>Zellweger Spectrum Disorder</keyword>
  <keyword>Peroxisomal Disorder</keyword>
  <keyword>Cholic Acid</keyword>
  <keyword>Cholbam</keyword>
  <keyword>Kolbam</keyword>
  <keyword>The Replace Registry</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cholic Acids</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

